News
- Home
- News
- IR
Investor relations
Total 23
| NO | Title | Writer |
|---|---|---|
| 3 | 2019.08.14 신주발행공고 | 관리자 |
| 2 | 2019.03.13 제 7기 결산공고 | 관리자 |
| 1 | 2018.12.31 기준일 및 주식명의개서 정지 공고 | 관리자 |
- iPSC Technology
- Korean iPSC Derived Cell Provider
- NEXEL
- ICH S7B CiPA
- Human Cardiomyocytes
- iPSC Derived Cardiomyocytes
- iPSC derived hepatocytes
- iPSC Derived Neurons
- MEA assay
- iPSC Derived Cell
- Cardiomyocyte Contractility
- 3D Tissue Contractility Analysis
- 3D Engineered Organoid Plates
- Cell Engineered Stretcher Plates
- 3D Organoid Plates
- Cell Nanosurface Plates
- Cardiac Safety Service
- hERG Assay
- Cardiotoxicity Test Screening
- Cardiomyocyte Viability
- iPSC Disease Model Service
- iPSC Reprogramming
- Drug Candidate Screening
- Drug Cardiotoxicity Test
- Disease Modeling